PIK3CA gene mutations and amplifications in Chinese patients with ovarian clear cell carcinoma

Area of Science:

• Oncology
• Molecular Biology
• Genetics

Background:

• Ovarian clear cell carcinoma (OCCC) is a distinct subtype of ovarian cancer.
• The role of genetic alterations, particularly in the PIK3CA gene, remains incompletely understood in OCCC.
• PIK3CA mutations are implicated in various cancers, influencing cell growth and survival pathways.

Purpose of the Study:

• To investigate the frequency and spectrum of mutations and amplifications in exons 9 and 20 of the PIK3CA gene in Chinese OCCC patients.
• To identify novel PIK3CA alterations and assess their functional impact.
• To determine if PIK3CA mutations and amplifications are mutually exclusive in OCCC.

Main Methods:

• Analysis of PIK3CA exons 9 and 20 in DNA from 51 Chinese OCCC patients.
• Mutation screening using established molecular techniques.
• Detection of gene amplifications.
• Functional assessment of a novel mutation (T544P) via AKT phosphorylation assays in cell culture.

Main Results:

• Activating missense mutations in PIK3CA were identified in 9 out of 51 (17.6%) OCCC cases.
• A novel mutation, T544P in exon 9, was discovered and demonstrated to enhance AKT phosphorylation in vitro.
• PIK3CA amplifications were present in 6 out of 51 (11.8%) cases.
• PIK3CA mutations and amplifications were found to be mutually exclusive events in this cohort.

Conclusions:

• The frequency of PIK3CA mutations and amplifications in Chinese OCCC patients is relatively low.
• The identified PIK3CA alterations, including a novel mutation, may contribute to OCCC pathogenesis.
• The mutual exclusivity of mutations and amplifications suggests distinct roles or regulatory mechanisms in OCCC.